Preliminary Results of Multi-Institutional Phase 1 Dose Escalation Trial Using Single-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer-Reference-Cited by-同舟云学术

Preliminary Results of Multi-Institutional Phase 1 Dose Escalation Trial Using Single-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer

Published:2022-03 Issue:3 Volume:112 Page:663-670
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Rahimi Asal,Simmons Ambrosia^ORCID,Kim D. Nathan,Leitch Marilyn,Haas Jonathan,Gu Xuejun,Ahn Chul,Gao Ang,Spangler Ann,Morgan Howard E.,Goudreau Sally,Seiler Stephen,Farr Deborah,Wooldridge Rachel,Haley Barbara,Bahrami Shohreh,Neufeld Sarah,Mendez Christopher,Alluri Prasanna,Rao Roshni,Timmerman Robert D.

Funder

Accuray Inc

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference26 articles.

1. Is the time right for five-fraction partial breast irradiation?;Wright;J Clin Oncol,2020

2. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): A randomised controlled equivalence trial;Veronesi;Lancet Oncol,2013

3. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): An international, prospective, randomised, non-inferiority phase 3 trial;Vaidya;Lancet,2010

4. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial;Vaidya;Lancet,2014

5. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial;Vaidya;BMJ,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Very accelerated partial breast irradiation in 1 or 2 days: Late toxicity and early oncological outcome of the GEC-ESTRO VAPBI cohort;Radiotherapy and Oncology;2024-05

2. MR-LINAC, a New Partner in Radiation Oncology: Current Landscape;Cancers;2024-01-08

3. Definitive ablative stereotactic partial breast irradiation in early stage inoperable breast cancer;Journal of Cancer Research and Clinical Oncology;2023-08-31

4. Pre-operative Radiation and Immunotherapy in the Treatment of Non-metastatic Breast Cancer;Current Breast Cancer Reports;2023-08-11

5. Preoperative single fraction breast radiotherapy: Intra-fraction geometric uncertainties and dosimetric implications;Physica Medica;2023-08